Todos Medical Reports Day 14 Update from Ongoing 30-Day Case Study of Paxlovid Rebound Patient
06 mai 2022 11h17 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, May 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength Including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim
02 mai 2022 10h02 HE
|
Todos Medical Ltd.
5-day and 30-day dosing regimen for 60-pill bottle allows for both support (5-day dosing) to reduce 3CL protease levels and to maintain (30-day dosing) low 3CL protease levels New York, NY, and...
Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th, 2022
27 avr. 2022 09h49 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical to Present at the Emerging Growth Conference
25 avr. 2022 10h51 HE
|
Todos Medical Ltd.
- Wednesday, April 27, 2022 at 10:00am – 10:45am EST - New York, NY, and Tel Aviv, ISRAEL, April 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a...
Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics
21 avr. 2022 07h59 HE
|
Todos Medical Ltd.
Strengthens Management Team and Positions the Company for Growth and Expansion New York, NY, and Tel Aviv, ISRAEL, April 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - Todos Medical, Ltd....
Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study
20 avr. 2022 08h01 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC Group
19 avr. 2022 07h23 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, April 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate of Free Sale with Daily and Acute Dosing on the Label
06 avr. 2022 08h46 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants
04 avr. 2022 09h11 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, April 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Update: Todos Medical Reports Fourth-Quarter and Full-Year 2021 Financial Results and Corporate Updates
01 avr. 2022 14h17 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, April 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions...